论文部分内容阅读
目的深入研究对肝炎患者进行检测的临床意义及用药指导。方法收集2012年3月～2013年6月在我院进行治疗的26例肝炎患者,其中甲肝患者有8例,乙肝患者10例,丙肝患者8例。在根据对其检测的临床意义和用药指导进行深入的探究。结果本组病例中需要使用肝炎药物包括23种,其中抗病毒药物2种,免疫调节药物3种,护肝药物13种,其它药物5种。结论根据肝炎相关的检测标准对患者进行检测,并具有重要的临床意义。对于肝炎患者的病因不同,药物治疗的方式中也存在较大的差异,对于甲肝患者一般表现为急性自限性经过,常选用支持疗法和对症治疗。乙肝和丙肝患者病因主要为慢性肝炎,主要采用抗病毒的治疗方式,服用免疫调节的药物以协同抗病毒,保护肝细胞,防止纤维化。
Objective To study in depth the clinical significance of detection of hepatitis patients and medication guidance. Methods A total of 26 patients with hepatitis treated in our hospital from March 2012 to June 2013 were collected, including 8 hepatitis A patients, 10 hepatitis B patients and 8 hepatitis C patients. Based on its detection of clinical significance and medication guidance in-depth exploration. Results There were 23 hepatitis drugs needed to be used in this group of patients, including 2 antiviral drugs, 3 immunomodulatory drugs, 13 hepatoprotective drugs and 5 other drugs. Conclusion The detection of patients based on hepatitis-related testing standards has important clinical significance. Hepatitis patients for different causes, there are also major differences in the way of drug treatment for patients with hepatitis A generally manifested as acute self-limiting after, often used to support the treatment and symptomatic treatment. The main causes of hepatitis B and hepatitis C patients with chronic hepatitis, the main anti-virus treatment, taking immunomodulatory drugs to synergize with anti-virus, protect liver cells and prevent fibrosis.